3 Biotech Gems to Stock Up on This Month Post author:Sam Post published:February 11, 2018 Post category:BioPharma A look at a few bargains in today’s choppy market. Source: BioSpace You Might Also Like Astellas Takes a $387 Million+ Loss as It Shuts Down SoCal's Agensys, Inc. July 26, 2017 Zymeworks Announces Partial Exercise Of Over-Allotment Option For Its Initial Public Offering May 25, 2017 Genentech's Top Cancer Prospect Flunks Phase III Test May 9, 2017
Zymeworks Announces Partial Exercise Of Over-Allotment Option For Its Initial Public Offering May 25, 2017
